Canada: Medical lab chains will combine forces, big bills to come for government
The Competition Bureau has announced that it will not take action to block two of British Columbia’s largest private medical chains from merging. LifeLabs plans to guy BC Biomedical, an acquisition that will mean LifeLab will now bill nearly $200 million a year to the government’s Medical Service Plan for state-funded testing. Despite concerns over the merger, the Medical Services Commission has reportedly approved for LifeLabs to run the former BC Biomedical labs. The parties expect to close the deal in April.
Featured News
Michigan Loses Antitrust Case Accusing Oil Giants of Blocking Renewable Energy
Sep 22, 2026 by
CPI
EU Antitrust Chief Says European SpaceX Challenger Will Face Full Merger Scrutiny
Sep 22, 2026 by
CPI
Canada Competition Bureau, Empire Settle Grocery Property-Control Probe
Sep 22, 2026 by
CPI
DoorDash $131.5 Million Settlement Puts New Focus on Gig Economy Regulation
Sep 22, 2026 by
CPI
UN Chief Presses for Global AI Framework With Independent Oversight
Sep 22, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – National Security
Sep 22, 2026 by
CPI
National Security in U.S. Antitrust Enforcement: Toward a More Disciplined Framework
Sep 22, 2026 by
Rod Rosenstein & Timothy Finley
The Department of War’s M&A Review Guidance: What Companies in the Defense Industry Need to Know
Sep 22, 2026 by
Eric Stocking & Paul Ney
National Security, Resilience and the Boundaries of Merger Control
Sep 22, 2026 by
Beatriz Marques
National Security and Competition: Building Resilient Telecommunications Networks
Sep 22, 2026 by
Roslyn Layton